glp 1 drugs covered by medicaid covers GLP-1 meds for obesity in just 13 states, analysis finds GLP-1s and The Payer Predicament

A 52% reduction in yearly support requests from these applicants, thanks to a more user-friendly design and updated technology

Chris Mertens, 35, of Menominee Falls, Wisconsin, said he had no trouble remembering to take the Wegovy pill every morning, which he did as part of a clinical trial in late 2022

Even more ambitious approaches are on the horizon

The choice depends on (1) the per-research-unit amount specified in the research protocol, (2) preference for syringe increment precision, (3) the peptide's solubility characteristics, and (4) how quickly the reconstituted vial will be used (lower volumes concentrate more research doses in a smaller volume of reconstituted solution)

Combining a GLP-1 agonist and a DPP-4 inhibitor for type 2 diabetes

Youll have ongoing access through messaging or scheduled visits